APA (7th ed.) Citation

Döhner, W., Anker, S. D., Butler, J., Zannad, F., Filippatos, G., Coats, A. J. S., . . . Packer, M. (2024). Uric aid and SGLT2 inhibition with empagliflozin in heart failure with preserved ejection fraction: The EMPEROR-preserved trial. JACC Heart failure, 12(12), . https://doi.org/10.1016/j.jchf.2024.08.020

Chicago Style (17th ed.) Citation

Döhner, Wolfram, et al. "Uric Aid and SGLT2 Inhibition with Empagliflozin in Heart failure with Preserved Ejection Fraction: The EMPEROR-preserved Trial." JACC Heart Failure 12, no. 12 (2024). https://doi.org/10.1016/j.jchf.2024.08.020.

MLA (9th ed.) Citation

Döhner, Wolfram, et al. "Uric Aid and SGLT2 Inhibition with Empagliflozin in Heart failure with Preserved Ejection Fraction: The EMPEROR-preserved Trial." JACC Heart Failure, vol. 12, no. 12, 2024, https://doi.org/10.1016/j.jchf.2024.08.020.